Epigenetics in Cardiac Hypertrophy and Heart Failure

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Genetics

Background:

• Heart failure (HF) is a global health challenge affecting millions.
• Epigenetic dysregulation is increasingly recognized in HF pathogenesis.
• Targeting epigenetic mechanisms presents a promising therapeutic avenue for HF.

Purpose of the Study:

• To review the current understanding of epigenomic alterations in heart failure.
• To summarize findings from human and animal studies on epigenetics in HF.
• To highlight the role of specific epigenetic mechanisms in HF pathophysiology.

Main Methods:

• Comprehensive literature search of epigenomic studies in HF.
• Analysis of studies focusing on DNA methylation, histone modifications, chromatin remodeling, and non-coding RNAs.
• Inclusion of both human and animal model data.

Main Results:

• Next-generation sequencing has advanced the understanding of epigenomic roles in HF.
• Key epigenetic modifications, including DNA methylation and histone alterations, are implicated in HF.
• Non-coding RNAs and ATP-dependent chromatin remodeling are critical in HF development.

Conclusions:

• Epigenetic regulation plays a significant role in heart failure.
• Understanding these mechanisms is crucial for developing novel HF therapies.
• Further research into epigenomic targets holds potential for effective HF treatment.